Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Gun goes off during MRI, injuring patient's son

A 40-year-old man was accompanying his mother to her MRI exam when the magnet caused his gun to fire, shooting him in the abdomen.

FDA approves new medication for type 2 diabetes

The newly approved SGLT2 inhibitor, bexagliflozin, is marketed under the name Brenzavvy. It is not recommended for patients with type 1 diabetes. 

Prestigious medical schools hide vital information from radiology residency programs

Would residency directors do better to favor high-achieving students from schools of more modest national status?

Tenet makes key leadership changes

Dallas-based Tenet Healthcare, the nation's largest ambulatory platform, has announced several leadership changes. 

 

An example if an implantable cardioverter defibrillator (ICD and its leads connected to the heart. As the leads or deveice wears out, there are recommendations to remove the leads and put in new ones. Image courtesy of RSNA

Infection, heart failure the most common reasons for early mortality after transvenous lead removal

Early mortality specifically related to complications during the TLR procedure was quite rare. 

Thumbnail

Healthcare workers are unhappy with their pay

Just over half of healthcare workers believe they are paid fairly for their work.

Thumbnail

Most radiology residents want more AI training, but few are getting it

The majority of radiology trainees have expressed interest in furthering their knowledge of artificial intelligence applications in the field, yet few are offered the opportunity to do so during the course of their education, according to new survey data.

Thumbnail

High hopes still afloat as promising Alzheimer’s drug loses bid for accelerated approval

The FDA has declined to accelerate approval of Eli Lilly’s highly anticipated Alzheimer’s drug, but the reason for the rejection may presage a forthcoming thumbs-up.